Yossi Maimon is President & VP at Protalix BioTherapeutics, Inc. (PLX). They have made 3 open-market trades across 1 company since 2009, most recently 2023-01-19.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $8K since 2015, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PLX | BUY | 2015-12-14 | 2015-12-15 | $0.78 | $8K | -14.1% | -15.0% | -7.0% |
| PLX | SELL · 10b5-1 | 2012-05-02 | 2012-05-04 | $7.13 | $898K | -14.1% | +1.0% | +1.0% |
| PLX | SELL · 10b5-1 | 2010-10-07 | 2010-10-08 | $9.67 | $677K | -14.1% | +1.0% | +1.0% |
| PLX | SELL · 10b5-1 | 2010-09-03 | 2010-09-08 | $8.07 | $565K | -14.1% | +1.0% | +1.0% |
| PLX | SELL · 10b5-1 | 2009-10-15 | 2009-10-19 | $9.46 | $1.4M | -14.1% | +1.0% | +1.0% |
| PLX | SELL · 10b5-1 | 2009-07-06 | 2009-07-08 | $5.11 | $255K | -14.1% | +1.0% | +1.0% |
| PLX | SELL | 2009-05-18 | 2009-05-19 | $4.00 | $120K | -14.1% | +1.0% | +1.0% |
| PLX | SELL | 2009-03-11 | 2009-03-13 | $2.24 | $109K | -14.1% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.